文献速递细菌感染、耐药与抗菌药物医院感染防控

口服胶囊粪菌移植清除碳青霉烯酶肠杆菌定植的宏基因组研究

Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective.
PubMed 文献 · Clin Infect Dis · 2021-01-01

这项前瞻性队列研究纳入15名碳青霉烯酶肠杆菌(CPE)携带者,给予口服胶囊粪菌移植(FMT)2天。1个月时9/15(完成2天治疗的13人中9人)达到CPE清除,清除者的肠道菌群组成与功能发生显著变化,失败者则无此变化,提示FMT可能通过菌群重塑实现去定植。

要点

  • 口服胶囊FMT 2天可使部分CPE携带者1个月时清除定植。
  • 清除者肠道菌群多样性和组成显著改变,失败者无此变化。
  • FMT后使用抗生素者β多样性显著降低,可能影响疗效。

核心结论

  • FMT清除CPE定植可能由肠道菌群的组成与功能改变介导。
  • FMT或可作为持续清除CPE的有效策略。
  • 研究为FMT抗CPE携带效果提供了生物学解释。

研究设计与样本

  • 前瞻性队列研究,所有同意的合格CPE携带者接受口服胶囊FMT 2天。
  • 共15名CPE携带者接受FMT,其中13人完成2天治疗。
  • 对供者和受者FMT前后肠道菌群进行综合宏基因组分析。

主要发现

  • 1个月时CPE清除率在15人中为9/15,在完成2天治疗的13人中为9/13。
  • 达到清除者的细菌群落β多样性和α多样性指标均发生显著变化,失败者未观察到。
  • FMT后样本的β多样性在分类和功能层面均按治疗结局聚类。
  • 接受FMT后抗生素的参与者β多样性显著降低。
  • 清除者FMT后肠杆菌科丰度下降,失败者则上升。

关键数值与推荐

  • 主要结局为1个月时CPE清除,定义为连续3次直肠拭子阴性,最后一次聚合酶链反应碳青霉烯酶基因亦阴性。
  • FMT方案为口服胶囊给药2天。
  • 临床试验注册号NCT03167398。

临床怎么用

  • 对CPE携带者可考虑口服胶囊FMT作为去定植策略,但需结合本地实际与患者选择。
  • FMT后应关注抗生素使用对菌群多样性和清除效果的可能影响。

局限性

  • 研究为前瞻性队列,样本量小(15人接受FMT,13人完成治疗),无对照组。
  • 单中心设计可能限制结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbapenemase-producing Enterobacteriaceae (CPE) infections lead to considerable morbidity and mortality. We assessed the potential of fecal microbiota transplantation (FMT) to eradicate CPE carriage and aimed to explain failure or success through microbiome analyses. METHODS: In this prospective cohort study, all consenting eligible CPE carriers received oral capsulized FMT for 2 days. Primary outcome was CPE eradication at 1 month, defined by 3 consecutive negative rectal swabs, the last also negative for carbapenemase gene by polymerase chain reaction. Comprehensive metagenomics analysis of the intestinal microbiome of donors and recipients before and after FMT was performed. RESULTS: Fifteen CPE carriers received FMT, 13 of whom completed 2 days of treatment. CPE eradication at 1 month was successful in 9/15 and 9/13, respectively. Bacterial communities showed significant changes in both beta and alpha diversity metrics among participants who achieved CPE eradication that were not observed among failures. Post-FMT samples' beta-diversity clustered according to the treatment outcome, both in taxonomy and in function. We observed a significant decrease in beta diversity in participants who received post-FMT antibiotics. Enterobacteriaceae abundance decreased in post-FMT samples of the responders but increased among failures. Functionally, a clear demarcation between responders (who were similar to the donors) and failures was shown, driven by antimicrobial resistance genes. CONCLUSIONS: Our study provides the biological explanation for the effect of FMT against CPE carriage. Decolonization of CPE by FMT is likely mediated by compositional and functional shifts in the microbiome. Thus, FMT might be an efficient strategy for sustained CPE eradication. CLINICAL TRIALS REGISTRATION: NCT03167398.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Bar-Yoseph H, Carasso S, Shklar S, et al. Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective. Clin Infect Dis. 2021. PMID: 32511695. doi:10.1093/cid/ciaa737

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。